Nov 4, 2021 9:21 pm EDT BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market
Oct 26, 2021 4:05 pm EDT BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
Oct 26, 2021 8:00 am EDT BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
Sep 23, 2021 9:00 am EDT BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
Sep 2, 2021 9:00 am EDT BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
Aug 31, 2021 9:00 am EDT BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program
Aug 19, 2021 6:00 am EDT BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook
Aug 9, 2021 11:57 am EDT BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering